Home › Idiopathic Thrombocytopenic Purpura › District of Columbia
Idiopathic Thrombocytopenic Purpura clinical trials in District of Columbia
6 studies for Idiopathic Thrombocytopenic Purpura are looking for participants at sites in District of Columbia.
Cities in District of Columbia
A Study of Pirtobrutinib in Participants With Immune Thrombocytopenia
- MedStar Georgetown University Hospital, Washington D.C.
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Sep 23, 2026 · NCT06721013A Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia
- Georgetown University Medical Center - Lombardi Comprehensive Cancer Center, Washington D.C.
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 18, 2026 · NCT06722235Safety, Tolerability, and Efficacy of NVG-2089 in Participants With Immune Thrombocytopenia
- Georgetown University Medical Center, Washington D.C.
RecruitingPhase 2
Ages 18 to 80 · All sexes · Updated Sep 14, 2026 · NCT07095127A Follow-up Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia
- Georgetown University Medical Center - Lombardi Comprehensive Cancer Center, Washington D.C.
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 9, 2026 · NCT06948318OM336 in Autoimmune Cytopenias
- Medstar, Washington D.C.
RecruitingPhase 1
Ages 18 to 75 · All sexes · Updated Sep 3, 2026 · NCT07083960A Study to Assess the Efficacy and Safety of Efgartigimod IV in Adult Participants With Primary Immune Thrombocytopenia
- Georgetown University Hospital, Washington D.C.
RecruitingPhase 3
Ages 18 and older · All sexes · Updated May 1, 2026 · NCT06544499From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.